首页 > 市场调查报告书 > 製药

再生医学

市场调查报告书

商品编码

1609789

2024-2032 年日本再生医学市场报告（按类型、应用、最终用户和地区）

Japan Regenerative Medicine Market Report by Type, Application, End User, and Region 2024-2032

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2023年日本再生医学市场IMARC Group达76亿美元。该市场受到一系列因素的推动，包括对移植排斥的担忧加剧、对再生骨科治疗的更大需求、对牙齿再生的日益关注以及伤口癒合药物的日益使用。

再生医学是生物医学科学中的一个有利领域，专注于修復受损的组织和器官。它涉及使用实验室培养的干细胞，将其安全地移植到体内，以促进骨骼、软骨、血管和重要器官等各种身体组成的再生。这种综合方法包括各种细胞和非细胞再生疗法，并结合了免疫调节和组织工程等技术。除了在组织修復中的作用外，再生医学在解决阿兹海默症、帕金森氏症、心血管疾病 (CVD)、骨质疏鬆症和脊髓损伤等持续性疾病方面也显示出巨大的前景。随着研究的进展，它对革命性的治疗方法提出了乐观的前景，这些治疗方法有可能显着提高患者的生活品质和整体医疗保健结果。

日本再生医学市场趋势：

日本再生医学市场正在经历大幅成长，这主要是由于老年人口的不断扩大。这种人口结构的变化与糖尿病、心臟病和骨关节炎等慢性疾病发病率的升高有关，从而极大地促进了市场的扩张。此外，对干细胞疗法和基因工程研究的日益关注正在促进再生医学领域的创新。为了组织再生和修復而越来越多地利用干细胞和其他细胞疗法进一步刺激了市场。值得注意的是，市场的积极发展轨迹是透过为再生医学研究和开发的进步分配资金和监管支持而得以维持的。生物技术的不断进步正在促进更精确、更有效的再生疗法的开发，从而促进市场的成长。此外，患者对再生治疗方案可用性的认识不断提高，这也成为市场扩张的额外催化剂。癌症发病率的增加以及对更有效、更适合患者的治疗方法的追求正在推动癌症治疗中对再生医学的需求，在市场的成长中发挥着重要作用。

日本再生医学市场细分：

类型见解：

干细胞治疗
生物材料
组织工程
其他的

应用见解：

骨移植替代品
骨关节疾病
皮肤科
心血管
中枢神经系统
其他的

最终使用者见解：

医院
专科诊所
其他的

竞争格局：

市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

日本再生医学市场迄今表现如何，未来几年又将如何表现？
COVID-19 对日本再生医学市场有何影响？
日本再生医学市场按类型划分是怎样的？
日本再生医学市场的应用基础如何细分？
日本再生医学市场的最终用户细分如何？
日本再生医学市场价值链的各个阶段是什么？
日本再生医学的关键驱动因素和挑战是什么？
日本再生医学市场的结构如何？
日本再生医学市场的竞争程度如何？

本报告回答的关键问题：

日本再生医学市场迄今表现如何，未来几年又将如何表现？
COVID-19 对日本再生医学市场有何影响？
日本再生医学市场按类型划分是怎样的？
日本再生医学市场的应用基础如何细分？
日本再生医学市场的最终用户细分如何？
日本再生医学市场价值链的各个阶段是什么？
日本再生医学的关键驱动因素和挑战是什么？
日本再生医学市场的结构如何？
日本再生医学市场的竞争程度如何？

干细胞治疗
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
生物材料
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
组织工程
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
其他的
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）

第 7 章：日本再生医学市场 - 细分：依应用分类

骨移植替代品
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
骨关节疾病
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
皮肤科
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
心血管
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
中枢神经系统
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
其他的
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）

第 8 章：日本再生医学市场 - 细分：依最终用户划分

医院
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
专科诊所
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
其他的
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）

第 9 章：日本再生医学市场 - 竞争格局

概述
市场结构
市场参与者定位
最佳制胜策略
竞争仪表板
公司评估象限

第 10 章：关键参与者简介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 11 章：日本再生医学市场 - 产业分析

驱动因素、限制因素和机会
- 概述
- 司机
- 限制
- 机会
波特五力分析
- 概述
- 买家的议价能力
- 供应商的议价能力
- 竞争程度
- 新进入者的威胁
- 替代品的威胁
价值链分析

第 12 章：附录

简介目录

Product Code: SR112024A19898

Japan regenerative medicine market size reached US$ 7.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.1 Billion by 2032, exhibiting a growth rate (CAGR) of 11.70% during 2024-2032. The market is being driven by a range of factors, including heightened worries about transplant rejection, a greater need for regenerative orthopedic treatments, an increasing focus on dental regeneration, and the growing utilization of medicine for wound healing.

Regenerative medicine is an auspicious field within biomedical science that focuses on repairing damaged tissues and organs. It involves the use of laboratory-cultivated stem cells, which are safely transplanted into the body to encourage the regeneration of various bodily components such as bones, cartilage, blood vessels, and essential organs. This comprehensive approach includes a variety of regenerative therapies, both cellular and acellular, incorporating techniques like immunomodulation and tissue engineering. Apart from its role in tissue repair, regenerative medicine shows great promise in addressing persistent conditions such as Alzheimer's, Parkinson's, cardiovascular diseases (CVDs), osteoporosis, and spinal cord injuries. As research progresses, it presents an optimistic outlook for revolutionary treatments that have the potential to significantly enhance patients' quality of life and overall healthcare outcomes.

Japan Regenerative Medicine Market Trends:

The Japan regenerative medicine market is experiencing substantial growth primarily due to the expanding elderly population. This demographic shift correlates with a heightened incidence of chronic ailments like diabetes, heart disease, and osteoarthritis, thus significantly contributing to the market's expansion. Moreover, the increasing focus on stem cell therapies and genetic engineering research is fostering innovation within the realm of regenerative medicine. The market is further stimulated by the growing utilization of stem cells and other cell-based therapies for the purpose of tissue regeneration and repair. Notably, the positive trajectory of the market is sustained by the allocation of funding and regulatory support for the advancement of regenerative medicine research and development. The continual advancements in biotechnology are facilitating the development of more precise and efficacious regenerative therapies, thereby bolstering the market's growth. Additionally, the rising awareness among patients regarding the availability of regenerative treatment options is serving as an additional catalyst for market expansion. The increasing occurrence of cancer and the quest for treatments that are both more efficient and accommodating for patients are driving the need for regenerative medicine in cancer treatment, playing a substantial role in the growth of the market.

Japan Regenerative Medicine Market Segmentation:

Type Insights:

Stem Cell Therapy
Biomaterial
Tissue Engineering
Others

Application Insights:

Bone Graft Substitutes
Osteoarticular Diseases
Dermatology
Cardiovascular
Central Nervous System
Others

End User Insights:

Hospitals
Specialty Clinics
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan regenerative medicine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan regenerative medicine market?
What is the breakup of the Japan regenerative medicine market on the basis of type?
What is the breakup of the Japan regenerative medicine market on the basis of application?
What is the breakup of the Japan regenerative medicine market on the basis of end user?
What are the various stages in the value chain of the Japan regenerative medicine market?
What are the key driving factors and challenges in the Japan regenerative medicine?
What is the structure of the Japan regenerative medicine market and who are the key players?
What is the degree of competition in the Japan regenerative medicine market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Regenerative Medicine Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Regenerative Medicine Market Landscape

5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)

6 Japan Regenerative Medicine Market - Breakup by Type

6.1 Stem Cell Therapy
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2018-2023)
- 6.1.3 Market Forecast (2024-2032)
6.2 Biomaterial
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2018-2023)
- 6.2.3 Market Forecast (2024-2032)
6.3 Tissue Engineering
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2018-2023)
- 6.3.3 Market Forecast (2024-2032)
6.4 Others
- 6.4.1 Historical and Current Market Trends (2018-2023)
- 6.4.2 Market Forecast (2024-2032)

7 Japan Regenerative Medicine Market - Breakup by Application

7.1 Bone Graft Substitutes
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2018-2023)
- 7.1.3 Market Forecast (2024-2032)
7.2 Osteoarticular Diseases
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2018-2023)
- 7.2.3 Market Forecast (2024-2032)
7.3 Dermatology
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2018-2023)
- 7.3.3 Market Forecast (2024-2032)
7.4 Cardiovascular
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2018-2023)
- 7.4.3 Market Forecast (2024-2032)
7.5 Central Nervous System
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2018-2023)
- 7.5.3 Market Forecast (2024-2032)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2018-2023)
- 7.6.2 Market Forecast (2024-2032)

8 Japan Regenerative Medicine Market - Breakup by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2018-2023)
- 8.1.3 Market Forecast (2024-2032)
8.2 Specialty Clinics
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2018-2023)
- 8.2.3 Market Forecast (2024-2032)
8.3 Others
- 8.3.1 Historical and Current Market Trends (2018-2023)
- 8.3.2 Market Forecast (2024-2032)

9 Japan Regenerative Medicine Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Regenerative Medicine Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis